Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ).
Hydration Pharmaceuticals Company Limited has had its securities suspended from quotation on the ASX after failing to lodge a required periodic report by the relevant deadline. The suspension, imposed under Listing Rule 17.5, affects trading from the start of 1 May 2026 and will remain in place until the company submits the overdue filing, after which its shares would normally be reinstated on the next trading day.
More about Hydration Pharmaceuticals Co. Ltd.
Hydration Pharmaceuticals Company Limited operates in the pharmaceutical and consumer health sector, focusing on hydration-related products. The company is listed on the ASX under the ticker HPC, giving it access to public capital markets and subjecting it to Australia’s continuous disclosure and reporting rules.
Technical Sentiment Signal: Sell
Current Market Cap: A$1.72M
See more data about HPC stock on TipRanks’ Stock Analysis page.